Prostate Cancer Overdiagnosis: Identifying Clinically Significant Disease to Avoid Unnecessary Treatment

Jump To Section

• The Problem of Overtreatment and Side Effects
• Defining Clinically Significant Prostate Cancer
• Personalizing Diagnosis by Age and Life Expectancy
• The Role of MRI in Prostate Cancer Diagnosis
• Global Standardization and Remote MRI Review
• Cloud Technology in Modern Healthcare

The Problem of Overtreatment and Side Effects

Prostate cancer overtreatment is a widespread clinical challenge. Dr. Mark Emberton, MD, emphasizes that not every diagnosed cancer requires aggressive therapy. This is because cancer treatments, including surgery and radiation, carry substantial risks and can cause significant long-term side effects.

These side effects often include urinary incontinence and erectile dysfunction, which can severely impact a patient's quality of life. The concept of overdiagnosis is difficult but vital for both clinicians and patients to understand to prevent harm from unnecessary interventions.

Defining Clinically Significant Prostate Cancer

The primary goal in modern prostate cancer care is not simply to find cancer, but to identify clinically significant cancer. Dr. Mark Emberton, MD, clarifies that this is a nuanced distinction. A clinically significant cancer is one that has the potential to grow, spread, and ultimately cause harm to the patient if left untreated.

This is contrasted with low-risk, indolent tumors that may never impact a man's health or longevity. Making this distinction accurately is the cornerstone of avoiding overdiagnosis and subsequent overtreatment.

Personalizing Diagnosis by Age and Life Expectancy

A key insight from Dr. Emberton is that clinical significance is not a fixed definition. It is profoundly influenced by the patient's age and overall life expectancy. A clinically significant cancer in a healthy 55-year-old man will look very different from one in an 80-year-old man.

For a younger patient with a longer life expectancy, even a smaller tumor might be deemed significant because it has more time to progress. Conversely, for an octogenarian, the threshold for significance is much higher, as other health factors and a shorter life expectancy change the risk-benefit calculus of treatment.

The Role of MRI in Prostate Cancer Diagnosis

Multiparametric MRI (magnetic resonance imaging) has revolutionized the diagnostic pathway for prostate cancer. Dr. Mark Emberton, MD, explains that MRI allows urologists to visualize the prostate and make informed judgments about which areas are suspicious. This imaging technology helps in deciding whether a prostate biopsy is necessary.

For instance, a slightly abnormal MRI in a young man may warrant a biopsy, while the same finding in an elderly man may not, provided no large, obvious tumor is seen. This triage capability is essential for reducing unnecessary biopsies and diagnoses of insignificant disease.

Global Standardization and Remote MRI Review

A major advantage of MRI technology is its high degree of standardization. Dr. Emberton confirms that an MRI scan performed in one location can be accurately read and interpreted by specialized radiologists elsewhere in the world. This standardization is crucial for ensuring diagnostic consistency and quality.

It enables patients in areas with less specialized expertise to benefit from second opinions and reviews by leading international experts without the need for travel, democratizing access to high-quality diagnostic care.

Cloud Technology in Modern Healthcare

The integration of cloud servers has further enhanced the utility of medical imaging. Dr. Mark Emberton, MD, highlights that MRI scans can be stored on secure, cloud-based DICOM servers. A DICOM (Digital Imaging and Communications in Medicine) server is the international standard for storing and transmitting medical images.

This allows authorized specialists anywhere to access, review, and interpret the images remotely. This cloud-based approach facilitates seamless collaboration among global experts, ensuring that every patient can receive a diagnosis based on the best available expertise, ultimately improving accuracy and reducing overdiagnosis.

Full Transcript

Dr. Mark Emberton, MD: Not all cancers need to be aggressively treated, because there are significant side effects and risks of cancer therapy. Cancer overtreatment is a common problem in prostate cancer.

But it's a difficult concept, cancer overdiagnosis.

Dr. Anton Titov, MD: But it's a very important concept.

Dr. Mark Emberton, MD: Yes. It's important to bring to people's attention that not all cancers need to be aggressively treated, because there are significant side effects and risks of cancer therapy.

Dr. Anton Titov, MD: Correct!

Dr. Mark Emberton, MD: The question in prostate is not to find cancer; it's to find clinically significant cancer. And cancer overdiagnosis is even more complicated than that. A clinically significant cancer in a 55-year-old man is going to look very different to a clinically significant cancer in an 80-year-old man.

MRI allows us to make those judgments on prostate cancer. So if I see a slightly abnormal MRI in a 55-year-old man, I have quite a low threshold for prostate biopsy. If I see a slightly abnormal MRI in an 80-year-old man, I'm happy.

As long as I can't see a reasonably large cancer in an 80-year-old, I'm content not to do prostate biopsy in that person, because an 80-year-old man has much less life expectancy than a 55-year-old man.

Dr. Anton Titov, MD: MRI technology is standardized, so it's possible to do MRI in one location of the world but have it read by very sophisticated specialists in another part of the world.

Dr. Mark Emberton, MD: Correct, correct! And of course, these days we will use cloud servers to review MRI. The MRI can be held in a cloud server and it can be accessed in a cloud-based DICOM server. Absolutely!